This study is testing a modified Vertical Sleeve Gastrectomy (mVSG) to see if it can better reduce heartburn and reflux (Gastroesophageal Reflux Disease or GERD) compared to the standard Vertical Sleeve Gastrectomy (cVSG) after weight loss surgery. Researchers want to see if the mVSG, which aims to preserve certain stomach structures, leads to less acid exposure in the esophagus. You might be able to join if you are 18-65 years old, have a BMI between 35-55, and have GERD with an acid exposure time of 4.9% or higher. The main goal is to see if mVSG results in less acid exposure 6-9 months after surgery. The study status is currently unclear.

Study design

This is a randomized clinical trial involving 44 participants across two sites. It compares a modified surgical procedure to the standard one.

What's involved

You would undergo either the modified or conventional sleeve gastrectomy. Tests like the Bravo pH test, esophageal manometry, and EndoFLIP would be performed before surgery and again 6-9 months after.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 6-9 months after surgery to assess acid exposure and other measures.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.